News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Icahn Tries to Replace 4 Directors at Genzyme Corporation
May 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NY Times -- The investor Carl C. Icahn wants to remove Genzyme’s chief executive, Henri A. Termeer, from the board of the company, according to a new proxy statement filed by Mr. Icahn.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details
February 10, 2026
·
2 min read
·
Tristan Manalac
Recruiting
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
February 10, 2026
·
4 min read
·
Nick Paul Taylor
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
Layoff Tracker
Delayed Notice Reveals 141 More Layoffs From Genentech in 2025
February 9, 2026
·
52 min read
·
BioSpace Editorial Staff